Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. STILLARGOL (protéinate d’argent)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

STILLARGOL (protéinate d’argent)

Medicine - Posted on Dec 08 2004 - Updated on Jun 12 2019
Active substance (DCI)
  • protéinate d’argent
history (2)
  • 12/8/04

    STILLARGOL 2 POUR CENT, solution pour instillation nasale 25 ml en flacon (Code CIP : 309 995-0)

    STILLARGOL 2 POUR CENT, solution pour instillation nasale 25 ml en flacon (Code CIP : 309 995-0)
    icône flèche
  • 7/7/04

    STILLARGOL 1% collyre Flacon de 25 ml (Code CIP :309 996 7) STILLARGOL 5% collyre Flacon de 25 ml (Code CIP :309 995 0)

    STILLARGOL 1% collyre Flacon de 25 ml (Code CIP :309 996 7) STILLARGOL 5% collyre Flacon de 25 ml (Code CIP :309 995 0)
    icône flèche
Technical information
Manufacturer
MAYOLI SPINDLER
Presentation

STILLARGOL 1% collyre
Flacon de 25 ml - Code CIP :3 09 996-7

STILLARGOL 5% collyre
Flacon de 25 ml - Code CIP : 309 995-0

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
Kzuukmw21sACvfs7